Publication | Closed Access

Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice

Alzheimer Transgenic MiceNeurodegenerative DiseasesAlzheimer's DiseaseGreen Tea Epigallocatechin-3-gallateMedicineDegenerative PathologyProtein MisfoldingAging-associated DiseasePharmacologyBiomolecular EngineeringOxidative Stress